IL161623A0 - Nicotin-or isonicotin benzothiazole derivatives - Google Patents

Nicotin-or isonicotin benzothiazole derivatives

Info

Publication number: IL161623A0
Authority: IL; Israel
Prior art keywords: isonicotin; nicotin; benzothiazole derivatives; benzothiazole; derivatives
Prior art date: 2001-11-19

Application number

IL16162302A

Other languages

English (en)

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-19

Filing date

2002-11-11

Publication date

2004-09-27

2002-11-11 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2004-09-27 Publication of IL161623A0 publication Critical patent/IL161623A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

IL16162302A 2001-11-19 2002-11-11 Nicotin-or isonicotin benzothiazole derivatives IL161623A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01127312		2001-11-19
PCT/EP2002/012562 WO2003043636A1 (en)	2001-11-19	2002-11-11	Nicotin-or isonicotin benzothiazole derivatives

Publications (1)

Publication Number	Publication Date
IL161623A0 true IL161623A0 (en)	2004-09-27

Family

ID=8179263

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL16162302A IL161623A0 (en)	2001-11-19	2002-11-11	Nicotin-or isonicotin benzothiazole derivatives
IL161623A IL161623A (en)	2001-11-19	2004-04-26	Nicotin-or isonicotin benzothiazole derivatives, their preparation and pharmaceutical compositions comprising them

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL161623A IL161623A (en)	2001-11-19	2004-04-26	Nicotin-or isonicotin benzothiazole derivatives, their preparation and pharmaceutical compositions comprising them

Country Status (38)

Country	Link
US (1)	US6620811B2 (xx)
EP (1)	EP1448198B1 (xx)
JP (1)	JP4226474B2 (xx)
KR (1)	KR100577110B1 (xx)
CN (1)	CN100546580C (xx)
AR (1)	AR039367A1 (xx)
AT (1)	ATE376831T1 (xx)
AU (1)	AU2002351955B2 (xx)
BR (1)	BR0214245A (xx)
CA (1)	CA2467552C (xx)
DE (1)	DE60223278T2 (xx)
DK (1)	DK1448198T3 (xx)
EA (1)	EA007502B1 (xx)
EC (1)	ECSP045109A (xx)
ES (1)	ES2294187T3 (xx)
GT (1)	GT200200232A (xx)
HR (1)	HRP20040396A2 (xx)
HU (1)	HUP0402161A3 (xx)
IL (2)	IL161623A0 (xx)
JO (1)	JO2290B1 (xx)
MA (1)	MA27083A1 (xx)
MX (1)	MXPA04004684A (xx)
MY (1)	MY126176A (xx)
NO (1)	NO20042576L (xx)
NZ (1)	NZ532802A (xx)
PA (1)	PA8558001A1 (xx)
PE (1)	PE20030713A1 (xx)
PL (1)	PL369517A1 (xx)
PT (1)	PT1448198E (xx)
RS (1)	RS39904A (xx)
RU (1)	RU2294933C2 (xx)
SI (1)	SI1448198T1 (xx)
TN (1)	TNSN04087A1 (xx)
TW (1)	TW200407134A (xx)
UA (1)	UA77462C2 (xx)
UY (1)	UY27542A1 (xx)
WO (1)	WO2003043636A1 (xx)
ZA (1)	ZA200403817B (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL153278A0 (en) *	2000-06-21	2003-07-06	Hoffmann La Roche	Benzothiazole derivatives
US8309570B2 (en) *	2001-06-07	2012-11-13	Analgesic Neuropharmaceuticals, Llc	Treatment of central neuropathic pain
US6734179B2 (en) *	2001-12-12	2004-05-11	Hoffmann-La Roche Inc.	Benzothiazoles
US7390813B1 (en)	2001-12-21	2008-06-24	Xenon Pharmaceuticals Inc.	Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
US20050119251A1 (en) *	2001-12-21	2005-06-02	Jian-Min Fu	Nicotinamide derivatives and their use as therapeutic agents
US6872833B2 (en)	2003-04-14	2005-03-29	Hoffmann-La Roche Inc.	Adenosine receptor ligands
CA2533594C (en)	2003-07-23	2013-04-02	Synta Pharmaceuticals, Corp.	Compounds for inflammation and immune-related uses
TW201038270A (en)	2003-07-30	2010-11-01	Xenon Pharmaceuticals Inc	Pyridazine derivatives and their use in the inhibition of stearoyl-CoA desaturase
MXPA06002943A (es) *	2003-09-19	2006-05-31	Hoffmann La Roche	Derivados de tiazolopiridina como ligandos del receptor de adenosina.
WO2005044793A2 (en)	2003-10-31	2005-05-19	Takeda Pharmaceutical Company Limited	Nitrogen-containing fused heterocyclic compounds
WO2005063743A1 (ja)	2003-12-26	2005-07-14	Kyowa Hakko Kogyo Co., Ltd.	チアゾール誘導体
CA2573198A1 (en) *	2004-07-06	2006-02-09	Xenon Pharmaceuticals Inc.	Nicotinamide derivatives and their use as therapeutic agents
RU2381227C2 (ru) *	2004-07-22	2010-02-10	Ф. Хоффманн-Ля Рош Аг	Замещенные бензотиазолы
KR100823799B1 (ko) *	2004-07-22	2008-04-21	에프. 호프만-라 로슈 아게	벤조티아졸 유도체
EP1773827B1 (en) *	2004-07-22	2010-02-17	F.Hoffmann-La Roche Ag	Benzothiazole derivatives
JP4958785B2 (ja) *	2004-09-20	2012-06-20	ゼノン・ファーマシューティカルズ・インコーポレイテッド	複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼインヒビターとしてのそれらの使用
ES2359840T5 (es) *	2004-09-20	2015-03-25	Xenon Pharmaceuticals Inc.	Derivados de piridina para inhibición de estearoil-CoA-desaturasa humana
EP2289510A1 (en)	2004-09-20	2011-03-02	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
AR051294A1 (es) *	2004-09-20	2007-01-03	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
CN101084212A (zh) *	2004-09-20	2007-12-05	泽农医药公司	杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
CA2580762A1 (en) *	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as therapeutic agents
CA2580845A1 (en) *	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
TW200624427A (en) *	2004-09-20	2006-07-16	Xenon Pharmaceuticals Inc	Heterocyclic derivatives and their use as therapeutic agents
TW200626154A (en) *	2004-09-20	2006-08-01	Xenon Pharmaceuticals Inc	Heterocyclic derivatives and their use as therapeutic agents
ATE400557T1 (de) *	2004-11-05	2008-07-15	Hoffmann La Roche	Verfahren zur herstellung von isonikotinsäurederivaten
JP5066514B2 (ja) *	2005-03-14	2012-11-07	ハイポイントファーマシューティカルズ，エルエルシー	ベンズアゾール誘導体、組成物及びβ−セクレターゼ阻害剤としての使用方法
EP2540296A1 (en) *	2005-06-03	2013-01-02	Xenon Pharmaceuticals Inc.	Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors
MX2009004314A (es) *	2006-11-13	2009-05-05	Pfizer Prod Inc	Diaril, dipiridinil y arilpiridinilderivados y usos de los mismos.
JP2012525389A (ja)	2009-04-27	2012-10-22	ハイポイントファーマシューティカルズ，リミティドライアビリティカンパニー	置換イソキノリン誘導体、医薬組成物、及びβ−セクレターゼ阻害剤としての使用方法
TWI548411B (zh)	2009-04-28	2016-09-11	Kyowa Hakko Kirin Co Ltd	Exercise disorder treatment
UA110097C2 (uk)	2009-09-02	2015-11-25		Терапевтичний агент для лікування розладів настрою
UA113383C2 (xx)	2009-09-02	2017-01-25		Терапевтичний агент для лікування тривожних розладів
JP2013522364A (ja) *	2010-03-23	2013-06-13	ハイポイントファーマシューティカルズ，リミティドライアビリティカンパニー	置換イミダゾ［１，２−ｂ］ピリダジン誘導体、医薬組成物、及びβ−セクレターゼ阻害剤としての使用の方法
JP5248585B2 (ja) *	2010-12-15	2013-07-31	ゼノン・ファーマシューティカルズ・インコーポレイテッド	治療薬としてのニコチンアミド誘導体およびそれらの使用
DE102011005232A1 (de)	2011-03-08	2012-09-13	AristoCon GmbH & Co. KG	Adenosin und seine Derivate zur Verwendung in der Schmerztherapie
ES2654143T3 (es)	2012-10-02	2018-02-12	Gilead Sciences, Inc.	Inhibidores de desmetilasas de histonas
WO2020103930A1 (zh) *	2018-11-22	2020-05-28	上海科技大学	噻唑并环类化合物、其制备方法、中间体和应用
DE102019110904B4 (de) *	2019-04-26	2022-01-20	Helmholtz-Zentrum Dresden - Rossendorf E. V.	N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-acetamid-Derivate und deren Verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3374550D1 (en)	1982-12-21	1987-12-23	Johnsen Jorgensen Plastics Ltd	Dispensing container
FI91859C (fi)	1987-06-17	1994-08-25	Eisai Co Ltd	Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
IL153278A0 (en) *	2000-06-21	2003-07-06	Hoffmann La Roche	Benzothiazole derivatives

2002
- 2002-11-05 US US10/288,100 patent/US6620811B2/en not_active Expired - Lifetime
- 2002-11-11 ES ES02787632T patent/ES2294187T3/es not_active Expired - Lifetime
- 2002-11-11 DK DK02787632T patent/DK1448198T3/da active
- 2002-11-11 JP JP2003545317A patent/JP4226474B2/ja not_active Expired - Fee Related
- 2002-11-11 HU HU0402161A patent/HUP0402161A3/hu not_active Application Discontinuation
- 2002-11-11 KR KR1020047007638A patent/KR100577110B1/ko not_active IP Right Cessation
- 2002-11-11 AT AT02787632T patent/ATE376831T1/de active
- 2002-11-11 CN CNB028228391A patent/CN100546580C/zh not_active Expired - Fee Related
- 2002-11-11 WO PCT/EP2002/012562 patent/WO2003043636A1/en active IP Right Grant
- 2002-11-11 DE DE60223278T patent/DE60223278T2/de not_active Expired - Lifetime
- 2002-11-11 PL PL02369517A patent/PL369517A1/xx not_active Application Discontinuation
- 2002-11-11 CA CA2467552A patent/CA2467552C/en not_active Expired - Fee Related
- 2002-11-11 MX MXPA04004684A patent/MXPA04004684A/es active IP Right Grant
- 2002-11-11 EP EP02787632A patent/EP1448198B1/en not_active Expired - Lifetime
- 2002-11-11 UA UA20040604552A patent/UA77462C2/uk unknown
- 2002-11-11 RS YU39904A patent/RS39904A/sr unknown
- 2002-11-11 EA EA200400598A patent/EA007502B1/ru not_active IP Right Cessation
- 2002-11-11 NZ NZ532802A patent/NZ532802A/en unknown
- 2002-11-11 AU AU2002351955A patent/AU2002351955B2/en not_active Ceased
- 2002-11-11 RU RU2004118425/04A patent/RU2294933C2/ru not_active IP Right Cessation
- 2002-11-11 SI SI200230637T patent/SI1448198T1/sl unknown
- 2002-11-11 BR BR0214245-7A patent/BR0214245A/pt not_active IP Right Cessation
- 2002-11-11 IL IL16162302A patent/IL161623A0/xx unknown
- 2002-11-11 PT PT02787632T patent/PT1448198E/pt unknown
- 2002-11-14 PA PA20028558001A patent/PA8558001A1/es unknown
- 2002-11-14 TW TW091133371A patent/TW200407134A/zh unknown
- 2002-11-15 PE PE2002001104A patent/PE20030713A1/es not_active Application Discontinuation
- 2002-11-18 AR ARP020104416A patent/AR039367A1/es unknown
- 2002-11-18 MY MYPI20024303A patent/MY126176A/en unknown
- 2002-11-18 GT GT200200232A patent/GT200200232A/es unknown
- 2002-11-18 JO JO2002114A patent/JO2290B1/en active
- 2002-11-18 UY UY27542A patent/UY27542A1/es not_active Application Discontinuation
2004
- 2004-04-26 IL IL161623A patent/IL161623A/en not_active IP Right Cessation
- 2004-05-05 HR HR20040396A patent/HRP20040396A2/hr not_active Application Discontinuation
- 2004-05-17 EC EC2004005109A patent/ECSP045109A/es unknown
- 2004-05-18 ZA ZA200403817A patent/ZA200403817B/en unknown
- 2004-05-18 TN TNP2004000087A patent/TNSN04087A1/en unknown
- 2004-05-18 MA MA27681A patent/MA27083A1/fr unknown
- 2004-06-18 NO NO20042576A patent/NO20042576L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TW200407134A (en)	2004-05-16
KR20050044535A (ko)	2005-05-12
US20030134854A1 (en)	2003-07-17
WO2003043636A1 (en)	2003-05-30
RU2004118425A (ru)	2006-01-10
UA77462C2 (en)	2006-12-15
NZ532802A (en)	2005-07-29
PE20030713A1 (es)	2003-08-23
CA2467552C (en)	2011-05-24
RU2294933C2 (ru)	2007-03-10
MY126176A (en)	2006-09-29
HUP0402161A2 (hu)	2005-02-28
IL161623A (en)	2010-11-30
RS39904A (xx)	2006-10-27
DE60223278D1 (de)	2007-12-13
GT200200232A (es)	2003-06-17
EA007502B1 (ru)	2006-10-27
ZA200403817B (en)	2005-05-23
MA27083A1 (fr)	2004-12-20
DE60223278T2 (de)	2008-08-14
PT1448198E (pt)	2007-12-11
PL369517A1 (en)	2005-04-18
ECSP045109A (es)	2004-06-28
HUP0402161A3 (en)	2010-06-28
JP2005522413A (ja)	2005-07-28
EP1448198A1 (en)	2004-08-25
EP1448198B1 (en)	2007-10-31
KR100577110B1 (ko)	2006-05-10
CA2467552A1 (en)	2003-05-30
EA200400598A1 (ru)	2005-02-24
DK1448198T3 (da)	2008-01-07
CN100546580C (zh)	2009-10-07
BR0214245A (pt)	2004-12-14
JO2290B1 (en)	2005-09-12
AU2002351955A1 (en)	2003-06-10
PA8558001A1 (es)	2003-07-28
SI1448198T1 (sl)	2008-02-29
AU2002351955B2 (en)	2007-03-15
UY27542A1 (es)	2003-05-30
AR039367A1 (es)	2005-02-16
MXPA04004684A (es)	2004-08-12
TNSN04087A1 (en)	2006-06-01
HRP20040396A2 (en)	2005-04-30
ES2294187T3 (es)	2008-04-01
ATE376831T1 (de)	2007-11-15
US6620811B2 (en)	2003-09-16
JP4226474B2 (ja)	2009-02-18
NO20042576L (no)	2004-06-18
CN1617722A (zh)	2005-05-18

Publication	Publication Date	Title
IL161623A0 (en)	2004-09-27	Nicotin-or isonicotin benzothiazole derivatives
PL370978A1 (en)	2005-06-13	Benzothiazole derivatives
IL153278A0 (en)	2003-07-06	Benzothiazole derivatives
EP1392664A4 (en)	2005-01-26	EPOTHILONE DERIVATIVES
IL160701A0 (en)	2004-08-31	3-substituted-4-pyrimidone derivatives
PL372123A1 (en)	2005-07-11	Thiazole derivatives
ZA200309522B (en)	2005-02-23	Substituted cyclohexane-1-4diamine derivatives
AP1850A (en)	2008-05-26	Spiroindolineplperidine derivatives
EG24050A (en)	2008-04-13	Heterocylocarboxamide derivatives
HK1077068A1 (en)	2006-02-03	Azolidinone-vinyl fused-benzene derivatives
IL166121A0 (en)	2006-01-15	Indole-3-sulphur derivatives
EP1522540A4 (en)	2011-08-10	AZAARENE DERIVATIVES
IL158388A0 (en)	2004-05-12	Novel arylheteroalkylamine derivatives
HUP0303449A3 (en)	2005-02-28	Substituted benzofuran-2-carboxamides derivatives
HUP0303186A3 (en)	2007-06-28	4-aminobenzopyran derivatives
HUP0401949A3 (en)	2009-07-28	4-imidazolin-2-one derivatives
PL375416A1 (en)	2005-11-28	Thiazole derivatives
HUP0500026A3 (en)	2008-02-28	N-heteroarylnicotinamide derivatives
AU2003222659A8 (en)	2003-11-03	23-o-substituted 5-o-mycaminosyltylonide derivatives
PL373947A1 (en)	2005-09-19	Benzothiazole derivatives
DE60207294D1 (en)	2005-12-15	Benzothiazole
HK1068607A1 (en)	2005-04-29	Phenylalkyloxy-phenyl derivatives
AU2003294938A8 (en)	2004-07-14	Epothilone derivatives
EP1364954A4 (en)	2009-10-28	Dicarba closo DODECARBORANDERIVATE
EP1531854A4 (en)	2006-06-28	O-DERIVATED NOCATHIACIN DERIVATIVES